AUPH FY 2024 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$235M+34.0% YoY

Gross Profit

$207M88.0% margin

Operating Income

-$5M-2.0% margin

Net Income

$6M2.4% margin

EPS (Diluted)

$0.04

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

$44M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$551M

Total Liabilities

$173M

Stockholders' Equity

$377M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$235M	$176M	+34.0%
Gross Profit	$207M	$161M	+28.2%
Operating Income	-$5M	-$92M	+94.9%
Net Income	$6M	-$78M	+107.4%